Based on the assumption that GLP-1R agonist was used as anti-diabetic medication among patients with DM and that these patients may experience the effects of GLP-1R agonist, we compared the levels of GLP-1R expression between patients with and without DM. Here, GLP1R is linked to diabetes mellitus.